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The benzophenanthridine alkaloid sanguinarine perturbs
microtubule assembly dynamics through tubulin binding
A possible mechanism for its antiproliferative activity
Manu Lopus and Dulal Panda
School of Biosciences and Bioengineering, Indian Institute of Technology Bombay, India
Microtubules are dynamic polymers composed of tub-
ulin dimers. They perform a variety of cellular func-
tions, including cell division, maintenance of cell shape
and structure, and cell signaling [1–4]. They are
important drug targets in several types of cancer.
Microtubule-targeted agents including paclitaxel, vin-
blastine and estramustine have been successfully used
in cancer chemotherapy, either as single agents or in
combinations. Many such compounds are undergoing
clinical trials [5–8].
The integrity of microtubules is considered essential
for the faithful segregation of chromosomes during
mitosis [3,8]. Most of the microtubule inhibitors,
including nocodazole, vinblastine, LY290181, crypto-
phycin-52, benomyl and griseofulvin, inhibit cell cycle
progression at mitosis [9–15]. These agents have been
shown to inhibit mitosis by selectively perturbing spin-
dle microtubule function at drug concentrations lower
than those required to depolymerize interphase micro-
tubules. For example, at their half-maximal antiprolif-
erative concentrations (IC50), benomyl, vinblastine,
griseofulvin and cryptophycin-52 induce little depolym-
erization of interphase microtubules, but they arrest
cells at the metaphase ⁄ anaphase transition and induce
cell death [7,8,12,14,15]. Although mitotic arrest is the
common mechanism for microtubule-targeted drugs,
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Sanguinarine has been shown to inhibit proliferation of several types of
human cancer cell including multidrug-resistant cells, whereas it has min-
imal cytotoxicity against normal cells such as neutrophils and keratino-
cytes. By analyzing the antiproliferative activity of sanguinarine in relation
to its effects on mitosis and microtubule assembly, we found that it inhibits
cancer cell proliferation by a novel mechanism. It inhibited HeLa cell pro-
liferation with a half-maximal inhibitory concentration of 1.6 ± 0.1 lm. In
its lower effective inhibitory concentration range, sanguinarine depolymer-
ized microtubules of both interphase and mitotic cells and perturbed chro-
mosome organization in mitotic HeLa cells. At concentrations of 2 lm, it
induced bundling of interphase microtubules and formation of granular
tubulin aggregates. A brief exposure of HeLa cells to sanguinarine caused
irreversible depolymerization of the microtubules, inhibited cell prolifer-
ation, and induced cell death. However, in contrast with several other
microtubule-depolymerizing agents, sanguinarine did not arrest cell cycle
progression at mitosis. In vitro, low concentrations of sanguinarine inhib-
ited microtubule assembly. At higher concentrations (> 40 lm), it altered
polymer morphology. Further, it induced aggregation of tubulin in the
presence of microtubule-associated proteins. The binding of sanguinarine
to tubulin induces conformational changes in tubulin. Together, the results
suggest that sanguinarine inhibits cell proliferation at least in part by per-
turbing microtubule assembly dynamics.
Abbreviations
ANS, 1-anilinonaphthalene-8-sulfonic acid; IC50, half-maximal inhibitory concentration; MAP, microtubule-associated protein.
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exceptions to this have also been reported. For
instance, halogenated derivatives of acetamidobenzoyl
ethyl ester were found to depolymerize cellular micro-
tubules and to arrest cells at the G1 ⁄S transition,
indicating that antitubulin agents can inhibit cell pro-
liferation without arresting cells at mitosis [16]. In
addition, it was shown that indanocine, a microtubule-
depolymerizing agent, inhibits proliferation of certain
types of noncycling tumor cell at G0 ⁄G1 phase [17].
Sanguinarine (13-methyl-[1,3]-benzodioxolo[5,6-c]-
1,3-dioxolo-[4,5-i]-phenanthridinium chloride) (Fig. 1),
a benzophenanthridine alkaloid derived from the plant
Sanguinaria canadensis, has been shown to have anti-
microbial, anti-inflammatory, antioxidant, and anti-
cancer activities [18–27]. It was reported to inhibit
proliferation of different types of cancer cell, including
human prostate carcinoma cells (LNCaP, PC-3 and
DU145), multidrug-resistant uterine cervical carcinoma
cells, human epidermoid carcinoma A431 cells, human
erythroleukemia K562 cells, and the premalignant cell-
line HaCaT [23,24]. However, sanguinarine was found
to be less toxic towards normal cells such as normal
human epidermal keratinocytes [20]. It inhibits cell
cycle progression at several stages of the cell cycle
including G0 ⁄G1 and G1 ⁄S [25]. Several mechanisms,
including upregulation of pro-apoptotic Bax, downreg-
ulation of the antiapoptotic protein Bcl2, inhibition
of mitogen-activated protein kinase phosphatase-1 and
nuclear factor kappaB (NF-jB), and suppression of
vascular endothelial growth factor-mediated angiogen-
esis have been proposed to explain the antiproliferative
activities of this alkaloid [22–28]. Further, it has been
shown that sanguinarine binds to tubulin, and this
inhibits the binding of colchicine to tubulin [29]. In
addition, sanguinarine has been shown to depolymerize
microtubules in HeLa cells [21] and inhibit tubulin
assembly in vitro [29]. However, how sanguinarine
inhibits microtubule assembly is not clear, and the
interaction of sanguinarine with cellular microtubules
in relation to its antiproliferative activity is not under-
stood. In this study, we examined the antiproliferative
effects of sanguinarine in relation to its ability to per-
turb mitosis and microtubule assembly.
We found that sanguinarine inhibited microtubule
assembly both in vitro and in cells and that the anti-
proliferative activity of sanguinarine correlates well
with its ability to depolymerize cellular microtubules.
However, it did not inhibit mitosis, indicating that its
antiproliferative mechanism of action is distinct from
most of the microtubule-targeted antimitotic agents.
The results indicate that sanguinarine inhibits cell pro-
liferation at least in part by depolymerizing cellular
microtubules. We also suggest a mechanism that may
explain the inhibitory effects of sanguinarine on micro-
tubule assembly.
Results
Sanguinarine depolymerized HeLa cell micro-
tubules and disorganized mitotic chromosomes
We first wanted to analyze the antiproliferative actions
of sanguinarine in HeLa cells. Sanguinarine inhibited
HeLa cell proliferation in a concentration-dependent
fashion with IC50 1.6 ± 0.1 lm (Fig. 1).
The effects of sanguinarine on the spindle micro-
tubules and the organization of the chromosomes in
mitotic HeLa cells are shown in Fig. 2. In control cells,
metaphase spindles were bipolar with a compact plate
of condensed chromosomes (Fig. 2A,D). At a low con-
centration of sanguinarine (0.5 lm), a concentration
that inhibited proliferation by 13%, the spindle micro-
tubule and chromosome organizations were very
similar to that of control cells, although a few chromo-
somes were not aligned at the metaphase plate
(Fig. 2B,E). At concentrations above 0.5 lm, sanguina-
rine disrupted the spindle microtubules and induced
abnormalities in the chromosome organization. For
example, 1 lm sanguinarine, which inhibited cell pro-
liferation by 35%, depolymerized the spindle micro-
tubules substantially (Fig. 2C). Further, at this
concentration, most of the spindles lost their bipolar
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Fig. 1. Inhibition of HeLa cell proliferation by sanguinarine. The
effect of sanguinarine on HeLa cell proliferation was determined by
measuring A550 using sulforhodamine B as described in Experimen-
tal procedures. The chemical structure of sanguinarine {13-methyl-
[1,3]-benzodioxolo-[5,6-c]-1,3-dioxolo-[4,5-i]-phenanthridinium} is
shown in the inset.
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organization, and the chromosomes became ball
shaped (Fig. 2C,F).
Sanguinarine depolymerized interphase microtubules
in a concentration-dependent manner (Fig. 3). For
example, 1.5 lm sanguinarine depolymerized inter-
phase microtubules significantly (Fig. 3B), 2 lm
sanguinarine depolymerized interphase microtubules
strongly (Fig. 3C), and 4 lm sanguinarine induced
extensive depolymerization of interphase microtubules
(Fig. 3D). In addition to depolymerizing the microtu-
bules, sanguinarine also disorganized them. Specific-
ally, it induced thick bundling of microtubules around
the nucleus (Fig. 3C, arrows). Further, granulated
aggregates of condensed tubulin were observed in the
presence of 4 lm sanguinarine (Fig. 3D). The results
show that the effective concentrations of sanguinarine
required to inhibit HeLa cell proliferation are similar
to those required to depolymerize interphase micro-
tubules (Figs 1 and 3).
The effects of sanguinarine on the mitotic index
were examined over a range of sanguinarine concentra-
tions. The mitotic index was 2.8 ± 0.4% in the
absence of sanguinarine, and 1.6 ± 0.3%, 1.3 ±
0.2%, and 0.6 ± 0.1% in the presence of 1, 2 and
3 lm sanguinarine, respectively, indicating that san-
guinarine did not block cells at mitosis. Consistent
with previous studies [22–24], we also found that
sanguinarine induced cell death in a concentration-
dependent manner (data not shown).
Sanguinarine inhibited HeLa cell proliferation
irreversibly
In previous work [29], sanguinarine was thought to
bind to tubulin covalently. We reasoned that, if
binding of sanguinarine to tubulin is covalent, it
would induce irreversible changes in cellular micro-
tubule organization and function. To examine the
Fig. 2. Effects of sanguinarine on microtub-
ule and chromosome organization of mitotic
HeLa cells. HeLa cells were incubated with
vehicle or different concentrations of san-
guinarine for 20 h, and microtubules and
chromosomes were visualized as described
in Experimental procedures. Microtubules in
the absence (A) and presence of 0.5 lM (B)
and 1 lM (C) sanguinarine are shown. (D–F)
Chromosome organization in the absence
and presence of 0.5 lM and 1 lM sanguin-
arine, respectively.
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effects of a brief exposure of sanguinarine in HeLa
cells, the cells were incubated with different concen-
trations of sanguinarine for 4 h. The medium was
then removed and replaced with drug-free medium.
The effects of the brief exposure of sanguinarine on
the proliferation of HeLa cells were analyzed 20 h
after drug removal. Sanguinarine inhibited cell prolif-
eration with an IC50 of 1.5 ± 0.5 lm, indicating
that the alkaloid exerted irreversible effects on its
cellular targets (Fig. 4A). We also examined the
effects of sanguinarine on microtubule organization
20 h after removal of the drug (Fig. 4B). Both mito-
tic spindle and interphase microtubules were signifi-
cantly depolymerized, suggesting that sanguinarine
permanently disrupted cellular microtubule assembly
(Fig. 4B).
Effects of sanguinarine on tubulin polymerization
The effects of sanguinarine on microtubule polymer-
ization were determined using two different tubulin
preparations: phosphocellulose-purified tubulin and
microtubule protein ]tubulin and microtubule-associ-
ated protein (MAP)]. Using a light-scattering tech-
nique, Wolff & Knipling [29] found that sanguinarine
inhibited tubulin assembly in the presence of paclitaxel.
However, they did not provide data on the effects of
sanguinarine on the amount of polymerized tubulin or
Fig. 3. Effects of sanguinarine on interphase
microtubules. Interphase microtubules of
HeLa cells are shown in the absence (A)
and presence of 1.5 lM (B), 2 lM (C) and
4 lM (D) sanguinarine. Arrows indicate the
bundling of interphase microtubules.
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on polymer morphology. Consistent with that study,
in our study sanguinarine appeared to reduce the rate
and extent of the paclitaxel-induced polymerization of
tubulin, as measured by 90  light scattering (Fig. 5A).
For example, 20 lm, 50 lm and 100 lm sanguinarine
reduced the light scattering signal by 7%, 16%, and
40%, respectively (Fig. 5A). In contrast with its strong
inhibitory effects on the light-scattering signal, san-
guinarine reduced the amount of polymerized tubulin
rather weakly (Fig. 5B). Specifically, 20 lm, 50 lm and
100 lm sanguinarine reduced the percentage of sedi-
mentable polymer mass by 10%, 17% and 22%,
respectively. Further, electron-microscopic analysis of
the assembly reaction showed that 20 lm sanguinarine
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Fig. 4. Irreversible inhibitory effects of san-
guinarine on HeLa cell proliferation (A) and
microtubule organization (B). After incuba-
tion of HeLa cells with sanguinarine for 4 h,
the sanguinarine-containing medium was
replaced by fresh medium. The effects of
the brief exposure of sanguinarine on the
proliferation of HeLa cells and its micro-
tubules were determined 20 h after the
removal of the alkaloid.
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Fig. 5. Sanguinarine inhibited microtubule
polymerization. Effects of sanguinarine on
paclitaxel-induced tubulin polymerization
(A–C). Paclitaxel-induced assembly of tubulin
(10 lM) was monitored in the absence (n)
and presence of 20 lM (d), 50 lM (m),
75 lM (.) and 100 lM (r) sanguinarine by
light scattering at 500 nm as described in
Experimental procedures (A). The effects of
sanguinarine on the sedimentable polymer
mass are shown in (B). The experiment was
performed four times. Each point represents
the mean ± SD. Electron micrographs of
microtubules in the absence and presence
of 20, 50 and 100 lM sanguinarine are
shown in (C). Images were taken at
43 000 · magnification using a Philips Fei
Technai G212 electron microscope. The bar
represents 500 nm. The effects of sanguin-
arine on the assembly of microtubule pro-
tein are shown in (D–F). Microtubule protein
(1.5 mgÆmL)1) was polymerized in the
absence and presence of different concen-
trations of sanguinarine. The assembly of
microtubule protein in the absence (n) and
presence of 20 lM ( ), 40 lM (d), 60 lM
(e), 75 lM (s) and 100 lM (.) sanguinarine
was monitored by light scattering at 500 nm
(D). The graph shows the effect of sanguin-
arine on the polymer mass (E). Electron
microscopic analysis of the assembly of
microtubule protein in the absence and
presence of sanguinarine is shown in (F).
Images were taken at 43 000 · magnific-
ation. The bar represents 500 nm. The
experiments were performed as described
in Experimental procedures.
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strongly reduced microtubule polymerization (Fig. 5C),
and that high concentrations (50 and 100 lm) of san-
guinarine altered polymer morphology (Fig. 5C).
Microtubule protein was polymerized in the absence
or presence of different concentrations of sanguinarine.
Similar to the effects of sanguinarine on the assembly
of pure tubulin, the alkaloid inhibited the rate and
extent of the assembly of microtubule protein, as
measured by light scattering (Fig. 5D). For example,
20 lm sanguinarine decreased the extent of the light-
scattering signal by 50%, and 40 lm sanguinarine
inhibited the signal by 75%. However, increasing the
concentration beyond 40 lm resulted in an increase in
the light-scattering signal. For example, in the presence
of 100 lm sanguinarine, the light-scattering signal was
similar to that of the assembly of microtubule proteins
in the absence of sanguinarine, indicating that at high
concentrations sanguinarine either induced aggregation
of tubulin or altered polymer morphology. The effect
of sanguinarine on the assembly of microtubule pro-
tein was determined by sedimenting the polymers.
Consistent with the scattering assay, low concentra-
tions (40 lm) of sanguinarine inhibited the assembly
of microtubule protein in a concentration-dependent
manner. For example, 40 lm sanguinarine reduced the
amount of polymerized microtubule protein by 40%
(Fig. 5E). However, at higher concentrations, the
inhibitory effect of sanguinarine on the assembled pol-
ymers was reversed, indicating that high concentrations
of sanguinarine induced aggregation of tubulin in the
presence of MAPs. Electron micrographs of polymers
formed in the absence and presence of 20, 50 and
100 lm sanguinarine are shown in Fig. 5F. At 20 lm,
sanguinarine clearly inhibited microtubule assembly,
and microtubules were shorter than the control micro-
tubules. High concentrations (50 and 100 lm) of san-
guinarine induced extensive aggregation of microtubule
proteins (Fig. 5F). Thus, the increase in the light-scat-
tering signal and sedimentable polymer mass in the
presence of high concentrations of sanguinarine appear
to be due to the formation of aggregates of micro-
tubule protein. The results indicate that sanguinarine
induced aggregation of tubulin dimers in the presence
of MAPs.
Sanguinarine copolymerized with tubulin into
polymers
Tubulin was polymerized in the presence of different
concentrations of sanguinarine, and the unbound san-
guinarine was separated from the polymer-bound
sanguinarine by sedimenting the polymers. The incor-
poration of sanguinarine per tubulin dimer into the
polymer increased with increasing concentration of
sanguinarine (Fig. 6). For example, the stoichiometries
of sanguinarine incorporation per tubulin dimer in the
polymer were 0.57 ± 0.1 and 1.1 ± 0.1 mol sanguina-
rine per mol tubulin in the presence of 10 and 20 lm
sanguinarine, respectively. The results indicate that
sanguinarine copolymerizes with tubulin into the tubu-
lin polymers.
Sanguinarine perturbed the secondary structure
of tubulin
The effect of sanguinarine on the secondary structure
of tubulin was examined by far-UV CD spectroscopy
(Fig. 7). Sanguinarine altered the amplitude of the far-
UV CD spectra of tubulin, indicating that it perturbed
the secondary structure of tubulin.
Effects of sanguinarine on tubulin)1-anilino-
naphthalene-8-sulfonic acid complex
fluorescence
Hydrophobic fluorescence probes such as 1-anilino-
naphthalene-8-sulfonic acid (ANS), bis-ANS and pro-
dan are routinely used to determine ligand-induced
conformational changes in tubulin [14]. Sanguinarine
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Fig. 6. Stoichiometry of incorporation of sanguinarine per tubulin
dimer in microtubules. Tubulin (1.2 mgÆmL)1) was polymerized in
buffer A containing 1 M glutamate and 1 mM GTP for 45 min at
37 C in the presence of different concentrations (10–60 lM) of
sanguinarine. Microtubules were spun down to separate free san-
guinarine molecules from the polymer-bound sanguinarine. The
stoichiometry of sanguinarine incorporation per tubulin dimer in the
pelleted polymer was calculated as described in Experimental pro-
cedures. Each point represents the mean ± SD from three inde-
pendent experiments.
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increased the fluorescence intensity of the tubulin–
ANS complex up to a certain concentration (Fig. 8).
For example, it was increased by 95% and 190% in
the presence of 10 lm and 20 lm sanguinarine, indica-
ting that sanguinarine induced conformational changes
in tubulin. However, high concentrations of sanguina-
rine (> 20 lm) reduced the fluorescence intensity of
the tubulin–ANS complex (Fig. 8). The results indicate
the presence of at least two different types of sanguina-
rine-binding site on tubulin.
Discussion
In this study, we found that sanguinarine inhibited
proliferation of HeLa cells apparently by a depolymer-
izing effect on cellular microtubules. Further, sanguin-
arine bound to tubulin in vitro induced conformational
changes in tubulin and inhibited polymerization of
tubulin into microtubules. Microtubule-depolymerizing
agents generally inhibit cell cycle progression at mito-
sis. Although sanguinarine depolymerized microtubules
both in vitro and in cells, it did not induce mitotic
block. The results suggest that the antiproliferative
mechanism of action of sanguinarine is different from
that of other microtubule-depolymerizing agents and
that at least some microtubule ⁄ tubulin inhibitors can
inhibit cell proliferation by a mechanism that does not
involve mitotic arrest.
Sanguinarine inhibited HeLa cell proliferation and
induced cell death without inhibiting mitosis. There-
fore, in addition to microtubules, sanguinarine may
have other cellular targets. Several mechanisms have
been suggested to explain the antiproliferative activities
of sanguinarine [22–28]. For example, it has been
shown that sanguinarine perturbs several signaling
pathways, including those operating through mitogen-
activated protein kinase phosphatase-1 and NF-jB
[22,26]. The role of microtubules in signal transduction
and intracellular transport is widely accepted [4].
The results obtained in this study indicate that the
modulation of the signaling pathways in cancer cells
by sanguinarine may partly involve microtubule
perturbation.
Sanguinarine depolymerized HeLa cell microtubules
in a concentration range that was similar to that
required to inhibit cell proliferation (Figs 2 and 3). At
a concentration of 2 lm, sanguinarine inhibited cell
proliferation by 70% and strongly depolymerized and
disorganized the interphase microtubule network
(Fig. 3). Several of the known microtubule-depolymer-
izing agents, including nocodazole, vinblastine, griseo-
fulvin, cryptophycin-52, LY290181 and benomyl,
inhibit cell proliferation by perturbing spindle organ-
ization and function in their lowest effective concen-
tration range without detectably depolymerizing
interphase microtubules [12–15]. For example, vinblas-
tine inhibited HeLa cell proliferation by 50% with no
apparent depolymerizing effects on interphase microtu-
bules [13]. Similarly, 5 lm benomyl inhibited HeLa cell
proliferation by 50% in the absence of any detectable
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Fig. 8. Effects of sanguinarine on the fluorescence of the tubulin–
ANS complex. The experiment was performed four times
(mean ± SD).
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Fig. 7. Sanguinarine perturbed the secondary structure of tubulin.
Tubulin (5 lM) in 25 mM Pipes buffer was incubated in the absence
(dotted line) and presence of 10 lm (dash dot line) and 30 lM (solid
line) sanguinarine for 30 min at 25 C, and the far-UV CD spectra
were recorded as described in Experimental procedures. The 222-nm
CD signals of tubulin were found to be – (90 ± 1.1), – (82 ± 1.3)
and – (77 ± 0.9) in the absence and presence of 10 and 30 lM san-
guinarine, respectively. The intensities of the CD signal of tubulin
at 222 nm in the absence and presence of sanguinarine were
significantly different (P < 0.01). The experiment was repeated 5
times.
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depolymerizing effects on interphase microtubules [14].
Interestingly sanguinarine, at its lowest effective con-
centration, significantly depolymerized and disorgan-
ized the interphase microtubule network (Fig. 3). In
addition, a brief exposure of the cells to sanguinarine
was sufficient to produce sustained depolymerization
of the microtubules (Fig. 4B). Rather than increasing
the percentage of mitotic cells, sanguinarine actually
reduced the percentage of them, demonstrating that it
does not induce mitotic block. Taken together, the
results obtained in this report suggest that the loss of
functional microtubules in sanguinarine-treated inter-
phase cells may prevent these cells from progressing
into mitosis. Similar modes of antiproliferative action
have been reported for other antitubulin agents. For
example, halogenated derivatives of acetamidobenzoyl
ethyl ester were found to depolymerize microtubules
and produce irreversible effects on cellular micro-
tubules [16]. These agents block cell proliferation at
the G1 ⁄S phase of the cell cycle. Indanocine, a tubulin-
binding drug, was also found to inhibit proliferation
of certain kinds of cancer cell without arresting cells at
mitosis [17].
Consistent with a previous report [29], sanguinarine
was found to reduce the light-scattering signal associ-
ated with paclitaxel-induced tubulin polymerization
(Fig. 5A). However, we found that sanguinarine only
modestly reduced the amount of sedimentable tubulin
polymer (Fig. 5B). For example, 100 lm sanguinarine
reduced the light-scattering intensity of paclitaxel-
induced tubulin assembly by 82%, whereas it reduced
sedimentable polymer mass by only 22%. The results
indicate that sanguinarine either altered polymer mor-
phology or induced aggregation of tubulin dimers.
Electron-microscopic analysis of the polymers showed
that sanguinarine altered polymer morphology
(Fig. 5C).
Sanguinarine exerted similar effects on the assembly of
microtubule protein (tubulin plus MAPs) (Fig. 5D–F).
At low concentrations (40 lm), it inhibited the assembly
of microtubule protein in a concentration-dependent
manner; however, high concentrations of sanguinarine
induced aggregation of microtubule proteins, suggesting
that sanguinarine induced tubulin aggregation in the
presence of MAPs (Fig. 5D–F). In this study, we found
that sanguinarine was incorporated with tubulin into
the tubulin polymers (Fig. 6). The binding of sanguina-
rine to tubulin induced conformational changes in
tubulin (Figs 7 and 8). Thus, the results suggest that
the incorporation of a large number of conformation-
ally altered tubulin dimers as tubulin–sanguinarine
complexes into microtubules produced nonmicrotubule
polymers.
A brief exposure of HeLa cells to sanguinarine was
sufficient to inhibit cell proliferation irreversibly
(Fig. 4A). In addition, the microtubule architecture
and chromosome organization in the cells were found
to be disrupted even 20 h after removal of the drug
(Fig. 4B). It was previously suggested that sanguina-
rine covalently binds to tubulin by forming a pseudo-
base with the cysteine residues of tubulin [29]. In
addition, we could not displace sanguinarine from the
purified tubulin–sanguinarine complex by denaturing
the preformed tubulin–sanguinarine complex using
high concentrations (6 m) of guanidine hydrochloride,
indicating that sanguinarine may bind to tubulin irre-
versibly (data not shown). Thus, the irreversible effects
of sanguinarine in HeLa cells may be explained by its
covalent binding to tubulin. Davis et al. [16] found
that halogenated derivatives of acetamidobenzoyl ethyl
ester inhibited proliferation of several types of cancer
cell by depolymerizing microtubules without arresting
cells at mitosis. Like sanguinarine, these agents were
also thought to bind to tubulin covalently and were
shown to exert irreversible effects on cells.
One of the major obstacles of effective drug action
is the efflux of the drug after its entry into cells by
protein pumps such as P-glycoprotein and multiple
drug resistance protein 1 [30]. Sanguinarine was also
found to be effective against multidrug-resistant HeLa
cells [23]. As sanguinarine binds tightly to tubulin, it
may be difficult for the efflux machinery to pump out
the drug. Thus, the tight binding of sanguinarine to
tubulin may be beneficial for cancer chemotherapy.
Experimental procedures
Materials
Sanguinarine chloride, GTP, Pipes, sulforhodamine B, Hoe-
chst 33342, propidium iodide and mouse monoclonal anti-
body to a-tubulin were purchased from Sigma (St Louis,
MO, USA). Phosphocellulose (P11) was purchased from
Whatman (Maidstone, UK). Alexa Fluor 568-labeled goat
anti-mouse IgG and ANS were purchased from Molecular
Probes (Eugene, OR, USA). All other reagents were of ana-
lytical grade.
Cell culture and proliferation assay
HeLa cells were grown in minimal essential media (Hime-
dia, Bangalore, India) supplemented with 10% (v ⁄ v) fetal
bovine serum, kanamycin (0.1 mgÆmL)1), penicillin G
(100 unitsÆmL)1), and sodium bicarbonate (1.5 mgÆmL)1) at
37 C in 5% CO2 as described previously [14]. Sulforhod-
amine B assay was performed with some modifications [14].
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Briefly, HeLa cells (1 · 104) were seeded in a poly lysine-
coated 96-well plate and grown for 20 h. Then, different
concentrations of sanguinarine were added to the wells, and
cells were incubated for 20 h. The cells were then fixed with
10% trichloroacetic acid for 1 h, rinsed with water, air-
dried, and stained with 0.4% sulforhodamine B in 1%
acetic acid for 1 h. Cell proliferation was determined by
measuring A550 with a microplate reader (Bio-Rad, Hercu-
les, CA, USA). The percentage inhibition of HeLa cell pro-
liferation in the presence of different concentrations of
sanguinarine was determined by subtracting A550 of pro-
tein-bound sulforhodamine B at time zero from all the
experimental data points [14]. The experiment was repeated
four times in duplicate.
Immunofluorescence microscopy
HeLa cells were seeded on coverslips at a density of
1 · 105 cellsÆmL)1 and grown in the absence and presence
of different concentrations of sanguinarine for 20 h [14].
Then, cells were fixed in 3.7% formaldehyde and permea-
bilized with ice-chilled methanol ()20 C). Nonspecific
binding sites were blocked by incubating the cells with
2% BSA in NaCl ⁄Pi for 15 min, and the cells were incu-
bated with mouse monoclonal antibody to a-tubulin
(1 : 150 dilution) for 2 h at 37 C. After incubation, cells
were washed twice with 2% BSA ⁄NaCl ⁄Pi. Then, the cells
were incubated with Alexa Fluor 568-labeled goat anti-
mouse IgG (1 : 300 dilution) for 1 h at 37 C. For stain-
ing the DNA, antibody-stained cells were incubated with
4¢,6-diamidino-2-phenylindole (1 lgÆmL)1) for 20 s. Micro-
tubules and chromosomes were observed using a Nikon
eclipse TE-2000U microscope. The images were analyzed
using Image-Pro Plus software. For studying the irrevers-
ible effects of sanguinarine, HeLa cells were treated with
sanguinarine for 4 h and then sanguinarine was removed
by replacing the sanguinarine-containing medium with
fresh medium.
Determination of mitotic indices and live/dead
cells
HeLa cells were treated with sanguinarine as described
above. The percentage of interphase and mitotic cells was
determined by Wright-Giemsa staining as described previ-
ously [14]. A minimum of 500 cells was counted per con-
centration of sanguinarine for each experiment. The
experiment was performed four times, and the data are
means of four independent experiments. To determine the
number of live ⁄dead cells by Hoechst 33342 ⁄propidium iod-
ide (1 lgÆmL)1) double staining, cells were treated with san-
guinarine for 20 h and then fixed with ice-cold methanol.
Live and dead cells were identified by blue (Hoechst 33342)
and red (propidium iodide) staining, under a fluorescence
microscope [31].
Purification of tubulin
Goat brain tubulin (depleted of MAPs) was isolated by two
cycles of polymerization and depolymerization in the pres-
ence of 0.4 m sodium glutamate and 10% (v ⁄ v) dimethyl
sulfoxide [14]. Tubulin was purified from the MAP-depleted
preparations by phosphocellulose chromatography and
stored at )80 C [14]. Microtubule protein (tubulin plus
MAPs) was isolated by two cycles of polymerization and
depolymerization in the presence of 4 m glycerol [32].
Tubulin concentration was determined by the method of
Bradford [33], using BSA as a standard.
Spectral measurements
Absorbance and fluorescence measurements were per-
formed using a V-530 UV-Visible spectrophotometer and
a FP-6500 spectrofluorimeter (Jasco, Tokyo, Japan),
respectively. Spectra were taken by multiple scans. A cu-
vette of 0.3 cm path length was used for all measure-
ments. The CD spectra were recorded after incubating
tubulin (5 lm) without or with different concentrations of
sanguinarine over the range 250–195 nm in a Jasco J-810
spectropolarimeter at 25 C, using a 0.1-cm path length
cuvette [34].
Inhibition of paclitaxel-induced polymerization
of tubulin
Purified tubulin (10 lm) was polymerized in buffer A
(25 mm Pipes, pH 6.8, 1 mm EGTA and 3 mm MgSO4) in
the presence of 10 lm paclitaxel and 1 mm GTP with dif-
ferent concentrations (0–100 lm) of sanguinarine at 37 C.
The rate and extent of polymerization were monitored
through 90  light scattering at 500 nm [35]. For the sedi-
mentation assay, tubulin (10 lm) was polymerized as des-
cribed above for 45 min at 37 C. After polymerization,
the samples were centrifuged at 30 C for 40 min at
56 000 g. The protein concentration in the supernatant was
measured, and polymer mass was calculated by subtracting
the supernatant concentration from the total protein con-
centration.
Transmission electron microscopy
Samples for electron microscopic analysis were prepared
as described previously [14]. Briefly, microtubules were
fixed with prewarmed 0.5% glutaraldehyde in buffer A
for 5 min. Samples (20 lL) were applied to carbon-coated
electron microscope grids (300-mesh) for 30 s and blotted
dry. The grids were subsequently negatively stained with
1% uranyl acetate and air-dried. The samples were
viewed using a Philips Fei Technai G212 electron micro-
scope. Images were taken at 43 000 · magnifications. The
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average number of microtubules per field of view was
determined by counting the number of polymers per
field.
Copolymerization of sanguinarine and tubulin
Tubulin (1.2 mgÆmL)1) was polymerized in buffer A con-
taining 1 m glutamate and 1 mm GTP for 45 min at 37 C
in the presence of different concentrations (10–60 lm) of
sanguinarine. Microtubules were spun down (52 000 g at
30 C) to separate free sanguinarine molecules from the
polymer-bound sanguinarine. The microtubule pellet was
washed carefully and then dissolved in PEM (25 mm pipes,
pH 6.8, 1 mm EGTA, 3 mm MgSO4) buffer. The concentra-
tion of microtubule-bound sanguinarine was estimated by
measuring A325. The incorporation stoichiometry of san-
guinarine per tubulin dimer in the polymer was calculated
by dividing the concentration of the bound sanguinarine by
the concentration of tubulin in the pellet. The nonspecific
precipitation (background signal) of sanguinarine was esti-
mated by incubating BSA (1.2 mgÆmL)1) with different
concentrations (10–60 lm) of sanguinarine in the presence
of GTP and magnesium for 30 min at 37 C, and then sedi-
menting the reaction mixtures in exactly the same way
as described for microtubule assembly. In the absence
of microtubules, the amount of sanguinarine precipitated
under identical experimental conditions was found to be
negligible (1%). We used the amount of sanguinarine preci-
pitated at each concentration of sanguinarine in the pres-
ence of BSA as a background to correct the experimental
data.
Effects of sanguinarine on tubulin–ANS complex
fluorescence
Tubulin (2 lm) in PEM buffer was incubated in the absence
and presence of various concentrations (5–60 lm) of san-
guinarine at room temperature for 10 min and then with
100 lm ANS for an additional 20 min. The fluorescence
intensity was measured at 470 nm using 380 nm as an excit-
ation wavelength [14].
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